Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
Completed
Kos Pharmaceuticals
Phase 4
2004-04-01
The purpose of this study is to evaluate the effectiveness of first-line treatment using
Niaspan (an extended release version of niacin) and statins versus other drugs that lower
lipid levels, in subjects with elevated fat levels in their blood (dyslipidemia). Statins are
a class of medication that is often prescribed to patients who need to lower their
cholesterol levels.
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2003-02-01
This study will evaluate patients who have coronary heart disease to determine if an
investigational drug will further lower cholesterol when taken in combination with an
approved cholesterol lowering medication.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
